1. Edirimanne S, Connor SJ. Incidental pancreatic cystic lesions. World J Surg. 2008; 32:2028–2037.
![crossref](/image/icon/bnr_ref_cross.gif)
2. de Jong K, Nio CY, Hermans JJ, et al. High prevalence of pancreatic cysts detected by screening magnetic resonance imaging examinations. Clin Gastroenterol Hepatol. 2010; 8:806–811.
![crossref](/image/icon/bnr_ref_cross.gif)
3. de Jong K, Bruno MJ, Fockens P. Epidemiology, diagnosis, and management of cystic lesions of the pancreas. Gastroenterol Res Pract. 2012; 2012:147465.
![crossref](/image/icon/bnr_ref_cross.gif)
4. Chang YR, Park JK, Jang JY, Kwon W, Yoon JH, Kim SW. Incidental pancreatic cystic neoplasms in an asymptomatic healthy population of 21,745 individuals: large-scale, single-center cohort study. Medicine (Baltimore). 2016; 95:e5535.
5. Balthazar EJ, Chako AC. Computed tomography of pancreatic masses. Am J Gastroenterol. 1990; 85:343–349.
6. Fernández-del Castillo C, Targarona J, Thayer SP, Rattner DW, Brugge WR, Warshaw AL. Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients. Arch Surg. 2003; 138:427–423. discussion 433–424.
7. Goh BK, Tan YM, Cheow PC, et al. Cystic lesions of the pancreas: an appraisal of an aggressive resectional policy adopted at a single institution during 15 years. Am J Surg. 2006; 192:148–154.
![crossref](/image/icon/bnr_ref_cross.gif)
8. Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006; 6:17–32.
![crossref](/image/icon/bnr_ref_cross.gif)
9. Tanaka M, Fernández-del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012; 12:183–197.
![crossref](/image/icon/bnr_ref_cross.gif)
10. Vege SS, Ziring B, Jain R, Moayyedi P. Clinical Guidelines Committee; American Gastroenterology Association. American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology. 2015; 148:819–822. quize12–13.
![crossref](/image/icon/bnr_ref_cross.gif)
11. Yoon WJ, Yoon YB, LEE KH, et al. The cystic neoplasms of the pancreas in Korea. Korean J Med. 2006; 70:261–267.
12. Gaujoux S, Brennan MF, Gonen M, et al. Cystic lesions of the pancreas: changes in the presentation and management of 1,424 patients at a single institution over a 15-year time period. J Am Coll Surg. 2011; 212:590–600. discussion 600–603.
![crossref](/image/icon/bnr_ref_cross.gif)
13. Madura JA, Wiebke EA, Howard TJ, et al. Mucin-hypersecreting intraductal neoplasms of the pancreas: a precursor to cystic pancreatic malignancies. Surgery. 1997; 122:786–792. discussion 792–793.
![crossref](/image/icon/bnr_ref_cross.gif)
14. Ferrone CR, Correa-Gallego C, Warshaw AL, et al. Current trends in pancreatic cystic neoplasms. Arch Surg. 2009; 144:448–454.
![crossref](/image/icon/bnr_ref_cross.gif)
15. Shimizu Y, Yamaue H, Maguchi H, et al. Predictors of malignancy in intraductal papillary mucinous neoplasm of the pancreas: analysis of 310 pancreatic resection patients at multiple high-volume centers. Pancreas. 2013; 42:883–888.
16. Hackert T, Fritz S, Klauss M, et al. Main-duct intraductal papillary mucinous neoplasm: high cancer risk in duct diameter of 5 to 9 mm. Ann Surg. 2015; 262:875–880. discussion 880–881.
17. Schmidt CM, White PB, Waters JA, et al. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg. 2007; 246:644–651. discussion 651–654.
18. Correa-Gallego C, Do R, Lafemina J, et al. Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram. Ann Surg Oncol. 2013; 20:4348–4355.
![crossref](/image/icon/bnr_ref_cross.gif)
19. Pelaez-Luna M, Chari ST, Smyrk TC, et al. Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol. 2007; 102:1759–1764.
![crossref](/image/icon/bnr_ref_cross.gif)
20. Fritz S, Schirren M, Klauss M, et al. Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas. Surgery. 2012; 152(3 Suppl 1):S74–S80.
![crossref](/image/icon/bnr_ref_cross.gif)
21. Reddy RP, Smyrk TC, Zapiach M, et al. Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer. Clin Gastroenterol Hepatol. 2004; 2:1026–1031.
![crossref](/image/icon/bnr_ref_cross.gif)
22. Murakami Y, Uemura K, Ohge H, Hayashidani Y, Sudo T, Sueda T. Intraductal papillary-mucinous neoplasms and mucinous cystic neoplasms of the pancreas differentiated by ovarian-type stroma. Surgery. 2006; 140:448–453.
![crossref](/image/icon/bnr_ref_cross.gif)
23. Yamao K, Yanagisawa A, Takahashi K, et al. Clinicopathological features and prognosis of mucinous cystic neoplasm with ovarian-type stroma: a multi-institutional study of the Japan pancreas society. Pancreas. 2011; 40:67–71.
![crossref](/image/icon/bnr_ref_cross.gif)
24. Park JW, Jang JY, Kang MJ, Kwon W, Chang YR, Kim SW. Mucinous cystic neoplasm of the pancreas: is surgical resection recommended for all surgically fit patients? Pancreatology. 2014; 14:131–136.
![crossref](/image/icon/bnr_ref_cross.gif)
25. Chang H, Gong Y, Xu J, Su Z, Qin C, Zhang Z. Clinical strategy for the management of solid pseudopapillary tumor of the pancreas: aggressive or less? Int J Med Sci. 2010; 7:309–313.
![crossref](/image/icon/bnr_ref_cross.gif)
26. Goh BK, Tan YM, Cheow PC, et al. Solid pseudopapillary neoplasms of the pancreas: an updated experience. J Surg Oncol. 2007; 95:640–644.
![crossref](/image/icon/bnr_ref_cross.gif)
27. Yang F, Jin C, Long J, et al. Solid pseudopapillary tumor of the pancreas: a case series of 26 consecutive patients. Am J Surg. 2009; 198:210–215.
![crossref](/image/icon/bnr_ref_cross.gif)
28. Sunkara S, Williams TR, Myers DT, Kryvenko ON. Solid pseudopapillary tumours of the pancreas: spectrum of imaging findings with histopathological correlation. Br J Radiol. 2012; 85:e1140–e1144.
![crossref](/image/icon/bnr_ref_cross.gif)
29. Goh BK, Tan YM, Yap WM, et al. Pancreatic serous oligocystic adenomas: clinicopathologic features and a comparison with serous microcystic adenomas and mucinous cystic neoplasms. World J Surg. 2006; 30:1553–1559.
![crossref](/image/icon/bnr_ref_cross.gif)
30. Lee SE, Kwon Y, Jang JY, et al. The morphological classification of a serous cystic tumor (SCT) of the pancreas and evaluation of the preoperative diagnostic accuracy of computed tomography. Ann Surg Oncol. 2008; 15:2089–2095.
![crossref](/image/icon/bnr_ref_cross.gif)
31. Khurana B, Mortelé KJ, Glickman J, Silverman SG, Ros PR. Macrocystic serous adenoma of the pancreas: radiologic-pathologic correlation. AJR Am J Roentgenol. 2003; 181:119–123.
![crossref](/image/icon/bnr_ref_cross.gif)
32. Salvia R, Fernández-del Castillo C, Bassi C, et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg. 2004; 239:678–685. discussion 685–677.
33. Moriya T, Hashimoto Y, Traverso LW. The duration of symptoms predicts the presence of malignancy in 210 resected cases of pancreatic intraductal papillary mucinous neoplasms. J Gastrointest Surg. 2011; 15:762–770. discussion 770–771.
![crossref](/image/icon/bnr_ref_cross.gif)
34. Chung JW, Chung MJ, Park JY, et al. Clinicopathologic features and outcomes of pancreatic cysts during a 12-year period. Pancreas. 2013; 42:230–238.
![crossref](/image/icon/bnr_ref_cross.gif)
35. Goh BK, Thng CH, Tan DM, et al. Evaluation of the Sendai and 2012 international consensus guidelines based on cross-sectional imaging findings performed for the initial triage of mucinous cystic lesions of the pancreas: a single institution experience with 114 surgically treated patients. Am J Surg. 2014; 208:202–209.
![crossref](/image/icon/bnr_ref_cross.gif)
36. Sahora K, Mino-Kenudson M, Brugge W, et al. Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series. Ann Surg. 2013; 258:466–475.
37. Uehara H, Ishikawa O, Katayama K, et al. Size of mural nodule as an indicator of surgery for branch duct intraductal papillary mucinous neoplasm of the pancreas during follow-up. J Gastroenterol. 2011; 46:657–663.
![crossref](/image/icon/bnr_ref_cross.gif)
38. Das A, Wells CD, Nguyen CC. Incidental cystic neoplasms of pancreas: what is the optimal interval of imaging surveillance? Am J Gastroenterol. 2008; 103:1657–1662.
![crossref](/image/icon/bnr_ref_cross.gif)
39. Walsh RM, Vogt DP, Henderson JM, et al. Management of suspected pancreatic cystic neoplasms based on cyst size. Surgery. 2008; 144:677–684. discussion 684–685.
![crossref](/image/icon/bnr_ref_cross.gif)
40. Serikawa M, Sasaki T, Fujimoto Y, Kuwahara K, Chayama K. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification. J Clin Gastroenterol. 2006; 40:856–862.
41. Wu BU, Sampath K, Berberian CE, et al. Prediction of malignancy in cystic neoplasms of the pancreas: a population-based cohort study. Am J Gastroenterol. 2014; 109:121–129. quiz 130.
![crossref](/image/icon/bnr_ref_cross.gif)
42. Leeds JS, Nayar MN, Dawwas M, et al. Comparison of endoscopic ultrasound and computed tomography in the assessment of pancreatic cyst size using pathology as the gold standard. Pancreatology. 2013; 13:263–266.
![crossref](/image/icon/bnr_ref_cross.gif)
43. Zhong N, Zhang L, Takahashi N, et al. Histologic and imaging features of mural nodules in mucinous pancreatic cysts. Clin Gastroenterol Hepatol. 2012; 10:192–198. 198.e1–2.
![crossref](/image/icon/bnr_ref_cross.gif)
44. Bick BL, Enders FT, Levy MJ, et al. The string sign for diagnosis of mucinous pancreatic cysts. Endoscopy. 2015; 47:626–631.
![crossref](/image/icon/bnr_ref_cross.gif)
45. Brugge WR, Lewandrowski K, Lee-Lewandrowski E, et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology. 2004; 126:1330–1336.
![crossref](/image/icon/bnr_ref_cross.gif)
46. Hammel P, Levy P, Voitot H, et al. Preoperative cyst fluid analysis is useful for the differential diagnosis of cystic lesions of the pancreas. Gastroenterology. 1995; 108:1230–1235.
![crossref](/image/icon/bnr_ref_cross.gif)
47. Attasaranya S, Pais S, LeBlanc J, McHenry L, Sherman S, DeWitt JM. Endoscopic ultrasound-guided fine needle aspiration and cyst fluid analysis for pancreatic cysts. JOP. 2007; 8:553–563.
48. van der Waaij LA, van Dullemen HM, Porte RJ. Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis. Gastrointest Endosc. 2005; 62:383–389.
![crossref](/image/icon/bnr_ref_cross.gif)
49. Gan SI, Thompson CC, Lauwers GY, Bounds BC, Brugge WR. Ethanol lavage of pancreatic cystic lesions: initial pilot study. Gastrointest Endosc. 2005; 61:746–752.
![crossref](/image/icon/bnr_ref_cross.gif)
50. Oh HC, Seo DW, Kim SH, Min B, Kim J. Systemic effect of endoscopic ultrasonography-guided pancreatic cyst ablation with ethanol and paclitaxel. Dig Dis Sci. 2014; 59:1573–1577.
![crossref](/image/icon/bnr_ref_cross.gif)
51. Moyer MT, Dye CE, Sharzehi S, et al. Is alcohol required for effective pancreatic cyst ablation? The prospective randomized CHARM trial pilot study. Endosc Int Open. 2016; 4:E603–E607.
![crossref](/image/icon/bnr_ref_cross.gif)
52. DeWitt J, McGreevy K, Schmidt CM, Brugge WR. EUS-guided ethanol versus saline solution lavage for pancreatic cysts: a randomized, double-blind study. Gastrointest Endosc. 2009; 70:710–723.
![crossref](/image/icon/bnr_ref_cross.gif)
53. Choi JH, Seo DW, Song TJ, et al. Longterm outcomes after endoscopic ultrasound-guided ablation of pancreatic cysts. Endoscopy. 2017 May 16. [Epub ahead of print].
![crossref](/image/icon/bnr_ref_cross.gif)
54. DeWitt J. Endoscopic ultrasound-guided pancreatic cyst ablation. Gastrointest Endosc Clin N Am. 2012; 22:291–302. ix-x.
![crossref](/image/icon/bnr_ref_cross.gif)
55. Oh HC, Brugge WR. EUS-guided pancreatic cyst ablation: a critical review (with video). Gastrointest Endosc. 2013; 77:526–533.
![crossref](/image/icon/bnr_ref_cross.gif)
56. Nougaret S, Reinhold C, Chong J, et al. Incidental pancreatic cysts: natural history and diagnostic accuracy of a limited serial pancreatic cyst MRI protocol. Eur Radiol. 2014; 24:1020–1029.
![crossref](/image/icon/bnr_ref_cross.gif)
57. Kwong WT, Hunt GC, Fehmi SM, et al. Low rates of malignancy and mortality in asymptomatic patients with suspected neoplastic pancreatic cysts beyond 5 years of surveillance. Clin Gastroenterol Hepatol. 2016; 14:865–871.
58. Singhi AD, Zeh HJ, Brand RE, et al. American Gastroenterological Association guidelines are inaccurate in detecting pancreatic cysts with advanced neoplasia: a clinicopathologic study of 225 patients with supporting molecular data. Gastrointest Endosc. 2016; 83:1107–1117.e2.
![crossref](/image/icon/bnr_ref_cross.gif)
59. Ridtitid W, DeWitt JM, Schmidt CM, et al. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes. Gastrointest Endosc. 2016; 84:436–445.
60. Lekkerkerker SJ, Besselink MG, Busch OR, et al. Comparing 3 guidelines on the management of surgically removed pancreatic cysts with regard to pathological outcome. Gastrointest Endosc. 2017; 85:1025–1031.
![crossref](/image/icon/bnr_ref_cross.gif)